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Xeroderma pigmentosum group A gene-deficient
mice easily develop skin cancers by ultraviolet radia-
tion. Natural killer cells play an important part in
tumor surveillance. To study whether ultraviolet
radiation-induced suppression of natural killer cell
function is involved in the high incidence of skin
tumors in patients with xeroderma pigmentosum,
we analyzed the number and activity of natural
killer cells in ultraviolet B-irradiated xeroderma
pigmentosum A model mice. The number of natural
killer cells in peripheral blood significantly decreased
after ultraviolet B-irradiation only in xeroderma
pigmentosum A mice, but those in the spleen were
not affected. As compared with the wild-type mice,
the xeroderma pigmentosum A mice displayed a
higher level of spontaneous splenic natural killer cell
activity (10%–15% vs 3%) and inducible natural killer
activity (30%–50% vs 20%–25%) after injection of
Xeroderma pigmentosum (XP) is an autosomalrecessive disorder clinically characterized by extremesensitivity to sunlight, a high incidence of skincancer, and frequent neurologic abnormalities(Robbins et al, 1974; Bootsma et al, 1998). Cultured
cells from patients with XP have a defect in an early step of
the nucleotide excision repair process of DNA lesions, such as
pyrimidine dimers caused by ultraviolet (UV) irradiation, and
therefore have a greatly increased sensitivity to the lethal effects of
UV radiation (Cleaver, 1968; Robbins et al, 1974; Bootsma et al,
1998); however, it is unclear how the defect causes the clinical
features of XP. Although much analysis at the cellular and molecular
levels has been done, in vivo studies are necessary to elucidate the
pathogenesis of XP. Such investigations can be now performed due
to the development of XP model mice.
Genetic complementation analysis by cell fusion has identified
at least eight complementation groups, designated group A through
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polyinosinic:polycytidylic acid. At 24 h after the last
irradiation of three and five daily consecutive exposures
to 500 mJ per cm2-ultraviolet B, however, the natural
killer activity in xeroderma pigmentosum A mice
decreased to 60 and 30% of the preirradiated level,
respectively, but it did not in the wild-type mice.
The depression of natural killer activity in xeroderma
pigmentosum A mice recovered to a normal level at
10 and 15 d after the last irradiation, respectively.
The high incidence of skin cancers in xeroderma
pigmentosum patients may be mainly due to a defect
in the repair of ultraviolet-damaged DNA of cutaneous
cells, and possibly also due to an intensified ultraviolet-
induced immunosuppression. Moreover, the present
study suggests that the enhanced ultraviolet-induced
impairment of natural killer function could be partially
involved in cancer development. Key words: immuno-
suppression/tumor immunity. J Invest Dermatol 112:
965–970, 1999
G, and a variant. (Aboussekhra and Wood, 1994). Group A XP
(XPA) is the most common form of this disease in Japan and shows
the most severe clinical symptoms. We have generated XPA gene-
deficient mice by gene targeting (Nakane et al, 1995). These XPA
gene-deficient mice display neither obvious physical abnormalities
nor pathologic alterations, but are defective in nucleotide-excision
repair and show a high incidence of skin tumors initiated by UVB,
like human XP (Nakane et al, 1995). Moreover, these mice develop
stronger and longer lasting ear swelling, and inflammation after
UVB exposure and treatment with psoralen plus UVA (PUVA)
than wild-type mice (Miyauchi-Hashimoto et al, 1996). The data
suggest that these XPA mice may be a useful model of human XP,
because the responses to UV radiation in the mice are very similar
to those in patients with XP.
The carcinogenic effects of UVB radiation on both human and
experimental animals have been well characterized (Laerum and
Iversen, 1981). UV radiation can function as a tumor initiator, a
tumor promoter, and a cocarcinogen. In addition, it has become
apparent that UVB radiation also has immunosuppressive effects
(Kripke, 1984; Ullrich, 1995), which may contribute to the etiology
of sunlight-induced skin cancer as well as the mutagenic properties
of UVB (Fisher and Kripke, 1982; Kripke, 1984; Ullrich, 1995).
It is possible that the UVB-induced immunosuppression could be
involved in the pathogenesis of skin cancer-prone disorders, such
as XP. In fact various defects in adaptive cell-mediated immunity
have been reported in XP, including impaired cutaneous responses
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to recall antigens (Dupuy and Lafforet, 1974; Wysenbeek et al,
1986) and DNCB sensitization (Dupuy and Lafforet, 1974; Morison
et al, 1985), a decrease in the ratio of circulating T helper/suppressor
cells (Wysenbeek et al, 1986), impaired lymphocyte proliferative
responses to mitogen (Dupuy and Lafforet, 1974; Wysenbeek et al,
1986), impaired production of interferon (IFN) in lymphocytes
(Gaspari et al, 1993), and reduced natural killer cell activity (Norris
et al, 1988; Mariani et al, 1992; Gaspari et al, 1993), although not
all patients have shown such abnormalities. We have already studied
the immunologic functions of XPA model mice. Although contact
hypersensitivity in XPA mice was induced equally to wild-type
mice, UVB-induced local and systemic immunosuppression to
contact hypersensitivity were greatly enhanced in XPA gene-
deficient mice (Miyauchi-Hashimoto et al, 1996). Thus, it is possible
that an enhanced impairment of the immune system by UVB
irradiation could be involved in the high incidence of skin cancer
in XP. In this paper, we studied the properties of natural killer cells
and the effects of UV radiation on natural killer cell function,
which have an important part in tumor surveillance.
MATERIALS AND METHODS
Animals The XPA gene-deficient homozygous (–/–) mice, which we
have established (Nakane et al, 1995), and wild-type (1/1) litter mice
were used. They have chimeric genetic backgrounds of CBA, C57BL/6,
and CD-1. Because the embryonic stem cells used for the targeting of the
XPA gene were derived from the F1 hybrid of CBA and C57BL/6, the
targeted embryonic stem cells were injected into eight-cell embryos of
CD-1 mice to obtain germ-line chimeras (Nakane et al, 1995). All mice
were male and 8–10 wk of age at the time of natural killer activity
testing, but within a single experiment all mice were age-matched. Each
experimental panel consisted of three to five mice.
UV irradiation The UVB source was a bank of six fluorescent sunlamps
(FL.20SE.30; Toshiba Medical Supply, Tokyo, Japan) with an emission
spectrum of 275–375 nm peaking at 305 nm. The UVA source was a bank
of 14 black lights (FL32S.BL; Toshiba Medical Supply, Tokyo, Japan) with
an emission spectrum of 300–430 nm peaking at 352 nm. The irradiance
of UVA and UVB was measured by a radiometer (UVR-305/365(II);
Toshiba Medical Supply). Hairs from the whole dorsal area of the mice
were clipped and removed, and then the mice were irradiated with UVB,
or UVA through a 4 mm plane of glass.
Hematologic and lymphocyte phenotype analysis Peripheral blood
was obtained by venipuncture and anticoagulated with heparin. Total white
blood cell (WBC) counts and lymphocyte counts were obtained for each
sample. Peripheral blood mononuclear cells were isolated using standard
Ficoll-Isopaque gradient centrifugation. The number of T cells and natural
killer cells were measured by flow cytofluorometric analysis. Fluorescein
isothiocyanate-labeled anti-mouse CD4 (L3T4) and anti-mouse natural
killer cells (2B4) were purchased from PharMingen (San Diego, CA).
Fluorescein isothiocyanate-labeled anti-mouse CD8 (Lyt 2) and anti-Thy
1,2 were purchased from Becton Dickinson (Bedford, MA). As controls,
fluorescein isothiocyanate-labeled mouse IgG2a and IgG2b (Dako,
Glostrup, Denmark) were used.
In vivo induction of natural killer cell activity The natural killer cell
activity was enhanced by injecting polyinosinic:polycytidylic acid (poly
I:C) (100 µg per 20 g K.W.) (Sigma, St. Louis, MO) i.p. 18 h before
harvesting the spleen cells.
Natural killer cell assays Cell cultures and assays were performed in
Dulbecco’s minimal essential medium (DMEM), supplemented with 10%
fetal calf serum, 100 IU per ml penicillin, and 100 µg per ml streptomycin.
As a target for natural killer cytolysis, the YAC-1 cell line (a DBA/2
lymphoma) was used. The natural killer cell activity was assessed in the
whole spleen of mice. These were removed aseptically, gently crushed,
and then suspended in DMEM. Lymphocyte suspensions were washed
twice and adjusted to 1 3 107 viable cells per ml. The YAC target cells
(5 3 106 cells per 100 µl) were labeled with Na251CrO4 (Amersham,
Arlington Heights, IL) for 1 h at 37°C (1 mCi per ml to 5 3 106 cells in
0.1 ml of DMEM). The 51Cr-release assay for the target was performed
in 96 well, U-bottomed microtiter plates for each sample, in triplicate.
Aliquots containing 1 3 104 target cells were added to each well containing
the appropriate number of effector cells in a final volume of 200 µl,
resulting in effector-to-target-cell ratios from 25:1 to 200:1. All plates were
incubated for 4 h in a humidified atmosphere of 5% CO2 in air. One
hundred milliliters of the supernatants were harvested and the radioactivity
was counted by a gamma counter (Packard, Tilburg, The Netherlands) as
counts per minute (cpm). The maximum release by lysis of the target cells
was estimated by incubating the labeled target cells with 2 N HCl and was
80%–90% of the total 51Cr incorporated. Background 51Cr release was
estimated by incubating the labeled target cells in DMEM without the
lymphoid effector cells, which yielded a release of between 5 and 15% of
incorporated 51Cr. The percentage specific lysis of the target cells was
calculated as (sample cpm – spontaneous cpm)/(maximum cpm – spon-
taneous cpm) 3 100%.
Statistical analysis A Student’s t-test was employed to determine the
statistical significance.
RESULTS
Peripheral lymphocyte and natural killer cell counts
decreased after UVB radiation in XPA mice When the mice
were not exposed to UVB, the leukocyte, lymphocyte, and natural
killer cell counts in the peripheral blood from (–/–) XPA mice
were slightly higher than those from (1/1) wild-type mice, but
not significantly. The effect of UVB irradiation on the blood cell
counts was examined. One group of mice was irradiated with a
single exposure of 500 mJ per cm2 UVB. The second group was
exposed to 500 mJ per cm2 UVB, three times on three consecutive
days. The third group received 500 mJ per cm2 UVB daily for five
consecutive days. Peripheral blood was collected 24 h after the last
irradiation. In the (1/1) control mice group, the WBC, lympho-
cyte and natural killer cell counts were not altered by any of the
exposures (Fig 1a). In (–/–) XPA mice group, the number of
WBC was not affected by UVB exposures. The lymphocyte count,
however, was significantly decreased (p , 0.05) after three or five
daily exposures to 500 mJ per cm2 UVB, and the natural killer cell
count was more significantly decreased (p , 0.01 or p , 0.005)
after three or five exposures, respectively. There was no difference
in the proportion of CD3, CD4, or CD8 lymphocytes in peripheral
blood between (–/–) and (1/1) mice. At 24 h after the single,
three, and five daily exposures to 500 mJ per cm2 UVB, there was
no change or only a slight but not significant decline of CD3,
CD4, and CD8 positive cells found in both strains.
Next, time course changes in the number of WBC, lymphocytes,
and natural killer cells in peripheral blood were studied after five
daily exposures to 500 mJ per cm2 UVB (Fig 1b). In (1/1) mice,
the WBC, lymphocyte, and natural killer cell counts reached a
minimum at 3 d after the last exposure and returned to preirradiation
levels by day 5, although these changes were not significant. In
(–/–) mice, the decrease in cell counts was more prominent and
longer-lasting than in wild-type mice. The number of WBC
showed a significant decrease (p , 0.05) only at 5 d after irradiation
in (–/–) mice. The counts of lymphocytes and natural killer cells
in (–/–) mice decreased 24 h after the last irradiation, reached a
minimum 3–5 d after irradiation, and recovered more slowly than
in control mice. By day 15, they returned to preirradiated levels.
Spontaneous and poly I:C-induced splenic natural killer cell
activity was higher in nonirradiated XPA mice than in wild-
type mice Because the number of peripheral natural killer cells
was small to perform the cytotoxicity assay, we used splenocytes
in this study. The natural killer activity of (–/–) XPA mice and
(1/1) wild-type mice was compared in nonirradiated conditions.
Figure 2 shows the spontaneous and poly I:C-inducible natural
killer cell activity in nonirradiated (1/1) and (–/–) mice. Spontan-
eous splenic natural killer cell activity in (1/1) mice was about
3% at an effector/target (E/T) cell ratio of between 50:1 and 200:1.
The (–/–) XPA mice displayed a higher level of natural killer
activity compared with (1/1) mice (range 10–15%; p , 0.05). In
both strains, poly I:C, a synthetic IFN-γ inducer, significantly
elevated splenic natural killer cell activity. While the poly I:C-
inducible natural killer activity in (1/1) mice was about 20%, that
in (–/–) XPA mice was between 30 and 50% at all E/T cell ratios
tested. Therefore, spontaneous and poly I:C-inducible natural killer
activity was higher in (–/–) XPA mice than in (1/1) mice.
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Figure 1. UVB irradiation induced a significant decrease in the
number of peripheral natural killer cells only in the XPA-deficient
mice. Data are expressed as mean number of blood cells (6 SD) per
1 µl in peripheral blood. (a) At 24 h after one, three, and five daily
exposures to 500 mJ per cm2 UVB, the number of natural killer cells
significantly decreased only in XPA-deficient mice. *p , 0.05, **p , 0.01,
***p , 0.005 compared with the nonirradiated group. (b) The time course
change in number of WBC, lymphocyte, and natural killer cells after UVB
radiation was shown. Only a slight (insignificant) decrease in the number
of them was found in wild-type mice. In contrast, the numbers especially
of natural killer cells, significantly decreased in XPA mice 3–5 d after the
last irradiation, and the decline lasted longer than that in wild-type mice.
Compared with the preirradiated level, significant differences were present
in the number of WBC from UVB-irradiated XPA-deficient mice (p , 0.05
at day 5), in the number of lymphocytes from UVB-irradiated XPA-
deficient mice (p , 0.05 at day 1 and day 10; p , 0.025 at day 3 and day
5), in the number of natural killer cells from UVB-irradiated XPA-
deficient mice (p , 0.05 at day 10; p , 0.025 at day 1; p , 0.01 at day
5; p , 0.0005 at day 3), and in the number in natural killer cells from
UVB-irradiated wild-type mice (p , 0.05 at day 3).
UVB irradiation inhibited natural killer cell activity in XPA
mice but not in wild-type mice Whether splenic natural killer
cell activity was impaired after UVB irradiation was determined in
(1/1) and (–/–) XPA mice. As spontaneous natural killer cell
activity was low in both strains, assays were also performed after a
standard in vivo natural killer cell induction with poly I:C. Three
groups from each strain were irradiated with 500 mJ per cm2
UVB as a single, three, or five daily exposure, respectively. The
spontaneous and poly I:C-inducible natural killer activity 24 h after
a single exposure of 500 mJ per cm2 UVB in (1/1) and (–/–)
XPA mice were comparable with those in the unirradiated of each
strain (data not shown). In (1/1) mice, the poly I:C inducibility
of natural killer cell activity was also not impaired after three and
five daily exposures with 500 mJ per cm2 UVB (Fig 3). The poly
I:C-inducible natural killer activity in (–/–) XPA mice, however,
decreased to 20%–30% and 10%–20% after three and five daily
exposures to 500 mJ per cm2 UVB, respectively. These natural
killer cell activity levels were equivalent to 60% and 30% of the
preirradiated level, respectively. The decline of natural killer activity
in XPA mice was not due to the decrease of natural killer cell
number, because the absolute number of splenic natural killer cells
Figure 2. The XPA-deficient mice displayed a higher level of
spontaneous and poly I:C-inducible splenic natural killer activity
than the wild-type mice. Data are expressed as percentage lysis of target
cells (6 SD) in an natural killer cytotoxicity assay. Significant differences
were present in the spontaneous natural killer activity between XPA-
deficient and wild-type mice (p , 0.05 at ratio 100:1 till 50:1; p , 0.025
at ratio 200:1) and in poly I:C-inducible natural killer activity between
both strains (p , 0.05 at ratio 200:1 till 50:1).
Figure 3. UVB irradiation impaired splenic natural killer activity
only in XPA-deficient mice. At 24 h after three and five daily exposures
to 500 mJ per cm2 UVB, the natural killer activity in XPA-deficient mice
decreased to 20%–30% and 10–20%, respectively, but was not decreased
in wild-type mice. Data are expressed as percentage lysis of target cells
(6 SD) in an natural killer cytotoxicity assay. *p , 0.025; **p , 0.005;
***p , 0.0005, compared with the value at the same E/T ratio in the
nonirradiated group.
was not changed 1 and 3 d after the five daily exposures to 500 mJ
per cm2 UVB. The mean number of splenic natural killer cells
(6 SD) in XPA mice was 4.9 3 106 6 1.4 at preirradiated point,
5.1 3 106 6 0.4 at 1 d after the last exposure and 6.4 3 106 6 0.2
at 3 d after the last irradiation.
Next, time course changes in inducible natural killer activity of
(–/–) XPA mice after three and five daily exposures to 500 mJ per
cm2 were examined. As shown in Fig 4(a), the inducible natural
killer activity in (–/–) XPA mice irradiated with 500 mJ per
cm2 UVB for three consecutive days decreased to 60% of the
nonirradiated level, 1 d after the last irradiation. The depression of
natural killer activity persisted for at least 5 d, then recovered to
the nonirradiated level at 10 d after the last irradiation. The recovery
of natural killer cell activity was slower in (–/–) XPA mice irradiated
with 500 mJ per cm2 UVB for 5 consecutive days than in those
irradiated for three consecutive days (Fig 4b). One day after the
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Figure 4. Time course changes in inducible natural killer activity
of XPA-deficient mice after three daily (a) and five daily (b)
exposures to 500 mJ per cm2 UVB. Data are expressed as percentage
of natural killer activity (6 SD) of those in the nonirradiated group tested
during the same experiment. One day after three daily (a) and five daily
(b) exposures to 500 mJ per cm2 UVB, inducible natural killer activity in
XPA-deficient mice decreased to 60% and 30% of the nonirradiated level,
respectively. The depression of natural killer cell activity persisted for at
least 5 d and 10 d after three daily (a) and five daily (b) exposures,
respectively. *p , 0.05; **p , 0.025; ***p , 0.005; ****p , 0.0005,
compared with the value at the same E/T ratio in the nonirradiated group.
five daily exposures of 500 mJ per cm2 UVB, inducible natural
killer activity in (–/–) XPA mice decreased to 30% of the non-
irradiated level. The depression of natural killer activity persisted
for at least 3 d, then gradually recovered, and returned to nearly
the nonirradiated level by day 15.
DISCUSSION
Both antigen-specific and nonspecific immune mechanisms are
involved in the anti-tumor reactions in the hosts. We have already
reported that the UVB-induced local and systemic immuno-
suppression to antigen-specific contact hypersensitivity was
greatly enhanced in XPA mice (Miyauchi-Hashimoto et al, 1996).
Epidermal Langerhans cells, which play a crucial part in skin
immunity, were also damaged at a lower UVB dose in XPA mice
than in wild-type mice. In this paper, we studied the function of
natural killer cells, which have a crucial part in antigen nonspecific
tumor immunity, in XPA mice. There was no difference in the
number of natural killer cells between the XPA mice and wild-
type strain, when the mice were either not irradiated or irradiated
with a single exposure of 500 mJ per cm2 UVB. When the mice
received three or five daily exposures to 500 mJ per cm2 UVB,
however, the number of lymphocyte and natural killer cell in
peripheral blood significantly decreased only in XPA mice. It has
been previously reported that UV radiation affects the population
and function of peripheral blood cells (Morison et al, 1979; Moscicki
et al, 1982; Hersey et al, 1983a,b); however, Hersey et al (1988)
reported minimal changes in the number of circulating CD161
cells as a result of irradiation and Gilmour et al (1993) also observed
no change in CD571 cells. Their findings suggest that the total
number of circulating natural killer cells remains unaltered by UV
radiation in normal humans, consistent with our finding that UV
radiation could not affect the number of natural killer cells in wild-
type mice. The number of circulating natural killer cells decreased
after UVB radiation only in XPA mice, suggesting that natural
killer cells in XPA mice are more sensitive to UV radiation. In the
present study, UV radiation almost totally deleted peripheral blood
natural killer cells in XPA mice, but did not affect splenic natural
killer cell numbers. This finding suggests that direct irradiation of
natural killer cells in the circulation is involved, consistent with an
in vitro study by Schacter et al (1983), which showed UV inhibition
of natural killer proliferative activity were mediated by nucleic
acids chromophore.
As regarding the function of natural killer cells, nonirradiated
XPA mice displayed a higher level of spontaneous and poly I:C-
inducible natural killer cell activity than wild-type mice. The
natural killer cell activity in XPA mice, however, was impaired by
UVB irradiation at doses that could not affect the natural killer
activity in wild-type mice. It has been demonstrated that UV
exposure depressed the activity of natural killer cells in rats (Goettsch
et al, 1993) and humans (Hersey et al, 1983; Toda et al, 1986;
Gilmour et al, 1993). Hersey et al (1988a) suggested that the
suppression of natural killer cell activity in vivo was due to UVA
rather than the UVB portion of the spectrum, because natural killer
activity was depressed by solarium radiation and was not prevented
by radiation filtering out UVB with Mylar sheeting. We also
examined the effect of UVA radiation on natural killer cell activity
in XPA and wild-type mice. Natural killer cell activity was not
impaired in either strain after irradiation with 15 J per cm2 of UVA
through a 4 mm plane of glass (data not shown).
There are some reports that XP patients have defects in cell-
mediated immunity, including impaired cutaneous responses to
recall antigens (Dupuy and Lafforet, 1974; Wysenbeek et al, 1986),
and a contact sensitizer (Dupuy and Lafforet, 1974; Morison et al,
1985). Hematologic abnormalities and the function of lymphocytes
and natural killer cells have been also examined in XP patients, but
the results are inconsistent. The numbers of circulating lymphocytes,
CD3 or CD4 positive T cells, and natural killer cells have been
reported to be normal (Norris et al, 1988, 1990; Gaspari et al, 1993)
to decreased (Mariani et al, 1992; Wysenbeek et al, 1986) in XP
patients. Complementation group of these patients were not
uniform; two patients of group C, one of group A, and three of
undetermined in the report of Gaspari et al, three of group D and
two of group G in the report of Norris et al, one of group D and
four of group C in the report of Mariani et al and not determined
in the report of Wysenbeek et al. Norris et al reported reduced
natural killer cell activity in five patients with XP (Norris et al,
1988, 1990). A subsequent report by this group, however, described
that an XP patient with multiple skin cancers, whose comple-
mentation group was not determined, had normal natural killer
cell activity (Anstey et al, 1991). Gaspari et al (1993) demonstrated
that natural killer cell function was 40% of the normal control in
five of eight XP patients, one of group A, two of group C, and
two of undetermined, but was normal in the three other XP
patients whose complementation group was not determined. They
concluded that XP patients are heterogeneous in their expression
of natural killer cell function.
Variances in reported natural killer cell activity among XP
patients may be due to the difference in complementation group.
Gaspari et al (1993) also found that the natural killer cell activity
from XP patients tested failed to show enhancement by poly I:C
and that their peripheral blood cells had a marked impairment of
IFN-γ production after stimulation with IFN inducers, such as
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poly I:C. Their findings suggested the possibility that impaired
IFN-γ production may be responsible for the defects in natural
killer cell activity. In the present study, both the number and
function of natural killer cells decreased in UV-irradiated XPA
mice, but were normal in nonirradiated XPA mice. Animal experi-
ments can be done under completely nonexposed conditions. These
findings suggest that the depression of number and activity in
natural killer cells reported in patients with XP may be caused
by unintentional UV exposure in the natural sunlight rather than
by constitutive abnormalities. It is possible that the heterogeneity
in natural killer cell activity in XP patients reported by Gaspari
et al may reflect the variety of degree of past UV exposure among
patients with XP. A higher natural killer cell activity in nonirradiated
XPA mice than in wild-type mice could be compensational
enhancement, because natural killer cells and the immune system
are more sensitive to UV radiation than those in wild-type
mice. Furthermore, UVB-induced suppression of natural killer cell
function in XPA mice could be due to apoptosis induced by DNA
damage or via excess cytokines released by UVB, such as tumor
necrosis factor-α.
The mechanism for suppression of natural killer activity in vivo
by UV radiation is not known. Groups of investigators reported
that in vitro UV irradiation of human peripheral blood mononuclear
cells results in a UV-dose-dependent suppression of natural killer
cell activity (Toda et al, 1986; Elmets et al, 1987; Schacter et al,
1983; Weitzen and Bonavida, 1984). It is possible that UV radiation
exerts a direct effect on natural killer cells circulating through the
dermal capillaries. The defect in repair of DNA damage in
XP cells may be involved in the enhancement of UV-induced
suppression of natural killer activity in XPA mice. Alternatively,
soluble mediators may be released from the epidermal or dermal
cells on UV irradiation that subsequently enter the circulation and
indirectly affect natural killer cell function. The proliferation and
activation of natural killer cells is induced by various cytokines,
such as interleukin (IL) 22, IL-12, and IFN-γ (Ortaldo et al,
1981; Ortaldo and Longo, 1988). In contrast, cytokines, such as
transforming growth factor-β and IL-10, and prostaglandin (PG)
E2, have been shown to inhibit natural killer cell activity. Excess
production of both PGE2 and IL-10, induced by UV exposure,
may cause the enhancement of UV-induced impairment of natural
killer cell activity in XPA mice. PGE2 suppresses natural killer
activity through the suppression of IFN-γ and IL-2 induction by
Th1 cells (Koren and Leung, 1982). IL-10 also suppresses natural
killer activity through the suppression of IFN-γ and IL-2 induced
by Th1 cells, macrophages, and natural killer cells (Liu et al, 1994).
In fact, we observed that PGE2 was synthesized in UVB-irradiated
skin significantly and increased in XPA mice more than in wild-
type mice (unpublished data). Although there has been no evidence
showing the enhancement of IL-10 production in UV-irradiated
XPA mice, it is possible that excess pyrimidine dimers remaining
in XPA mice skin after UV radiation stimulate IL-10 synthesis.
Nishigori et al (1996) showed that pyrimidine dimers induced by
UVB triggered IL-10 production. Treatment with liposomal T4
endonuclease V, the repair enzyme of pyrimidine dimers, inhibited
UVB-induced IL-10 by keratinocytes in vitro, or in serum of mice
in vivo. Thus, enhanced production of PGE2 and/or IL-10 in UVB-
irradiated XPA mice could be responsible for the enhancement of
a UVB-induced impairment of natural killer activity in XPA mice
through the inhibition of IFN-γ and/or IL-2 production. The
impairment of IFN-γ production was demonstrated by Gaspari et al
(1993) in peripheral blood mononuclear cells in patients with XP,
although it is not clear whether this impairment is a constitutive
abnormality or caused by UVB irradiation. Furthermore, UVB-
induced suppression of natural killer cell numbers and function in
XPA mice could be due to apoptosis induced by UVB-induced
DNA damage, or by the expression of Fas/Fas ligand and/or excess
UVB-released cytokines, such as tumor necrosis factor-α.
Not only skin cancers but also internal malignancies have
been reported to be increased in XP patients. Although the
pathomechanisms remain unknown, the impaired natural killer
cell activity may be involved in the development of internal
malignancies in XP patients. The present study seems to support
this possibility. In fact, natural killer cell function is generally
depressed in patients with advanced malignancies (Vose, 1980).
In conclusion, the high incidence of skin cancers in XP patients
may be mainly due to a defect in the repair of UV-damaged DNA
of cutaneous cells. Moreover, a series of our experiments using
XPA model mice suggests that enhanced UV-induced immuno-
suppression and UV-induced impairment of natural killer functions
could be partially involved in the cancer development of XP
patients.
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